ADMPライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 9月 2023 @ 04:59):

Stats
本日の出来高	119 482
平均出来高	3.11M
時価総額	7.25M
EPS	$0 ( 2024-03-14 )
次の収益日	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0764
ATR14	$0.190 (30.44%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-23	Dorbin John W. Jr.	Buy	70 000	Employee Stock Option (right to buy)
2023-10-23	Dorbin John W. Jr.	Buy	0
2023-10-16	Cohen Seth	Buy	151 416	Employee Stock Option (right to buy)
2023-10-16	Cohen Seth	Buy	0
2023-09-15	Versi Ebrahim	Buy	729 200	Common Stock

INSIDER POWER
93.18
Last 88 transactions
Buy: 1 947 813 \| Sell: 1 308 563

ボリューム相関

長: -0.04 (neutral)

短: -0.22 (neutral)

Signal:(43.501) Neutral

Adamis Pharmaceuticals 相関

10 最も正の相関
AGRX	0.964
VLCN	0.956
VRAY	0.949
HAIN	0.947
NDLS	0.944
IONM	0.943
NSTG	0.943
ENSC	0.941
CLPT	0.941
NEXT	0.938

10 最も負の相関
ADSE	-0.961
NWLI	-0.96
PRSRU	-0.954
EVLV	-0.942
BTWN	-0.934
STCN	-0.932
CCRC	-0.932
ARNA	-0.931
DSEY	-0.931
DMRC	-0.928

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Adamis Pharmaceuticals 相関 - 通貨/商品

0.70
( moderate )

0.66
( moderate )

0.00
( neutral )

0.74
( moderate )

-0.30
( neutral )

-0.62
( weak negative )

Adamis Pharmaceuticals 財務諸表

Annual	2022
収益:	$4.76M
総利益:	$-1.43M (-30.10 %)
EPS:	$-12.24

FY	2022
収益:	$4.76M
総利益:	$-1.43M (-30.10 %)
EPS:	$-12.24

FY	2021
収益:	$2.21M
総利益:	$-4.66M (-211.14 %)
EPS:	$-0.320

FY	2020
収益:	$16.53M
総利益:	$1.63M (9.88 %)
EPS:	$-0.640

Financial Reports:

No articles found.

Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.